Home » Laboratories » F4. Simulation

Status Quo

Minimally invasive surgery is the present and future of surgical interventions, and the development of practical skills in this area requires a premature initiation. To diminish the laparoscopic learning curve, to reduce human errors and protect hospital equipment, beginners in laparoscopy can develop their standard abilities using medical simulation.


Using medical simulation through virtual reality with advanced technology is one of the best ways to develop these standard abilities to beginners like doctors in various surgical specialties.

The aim is to teach and evaluate the knowledge and abilities that a surgeon requires in order to effectively and safely perform a laparoscopic cholecystectomy, laparoscopic appendectomy, and a diagnostic laparoscopy.

Courses are built around hands-on training on simulators and interactive discussions of experts.


Training on the simulator

Much of the course is devoted to deliberate and repetitive training of basic and procedural laparoscopic skills on simulators.

The performance parameters provided by the simulators during the training provide the participants and the trainers with direct feedback on stage achievements. Within the course program described, participants can adapt their training to individual needs and training style.

Training simulator to monitor vital functions during complex procedures: HAL S301



The strategic goal is to create research cores with advanced technological facilities in the form of research platforms by associating preclinical research laboratories and clinical research centers within the Fundeni Clinical Institute in a unique entity.

The newly created structure provides logistical support for biomedical research through the coordination of studies, quality management, data monitoring, dissemination of good clinical practice, database management and data analysis. Infrastructure is also dedicated to the production of vectors for gene and cellular therapy, as well as for the acquisition of new agents with therapeutic potential in digestive affection.

Subscribe to
CEMT Newsletter

For more informations please subscribe to our newsletter.
Fields with * are required.